Skip to main content
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: Biol Psychiatry. 2013 Sep 30;76(2):160–167. doi: 10.1016/j.biopsych.2013.09.019

Figure 1. Quantitative PCR analysis of IFITM mRNA levels in the prefrontal cortex in schizophrenia.

Figure 1

Transcript levels for each schizophrenia subject relative to the matched healthy comparison subject are indicated by open circles. Data points to the left of the unity line indicate higher mRNA levels in the schizophrenia subject relative to the healthy comparison subject. Mean mRNA levels (± SD) in schizophrenia subjects were statistically significantly higher for IFITM1 (0.027 ± 0.017) and IFITM2/3 (0.078 ± 0.058) relative to healthy comparison subjects (IFITM1: 0.016 ± 0.005; IFITM2/3: 0.036 ± 0.011).